Merck, J&J, Bristol Myers Squibb CEOs face Senate drug price hearing
(L-R) Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner,...
Read More
Select Page
Posted by Times Reporter | Feb 9, 2024 | Health |
(L-R) Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner,...
Read MorePosted by Times Reporter | Feb 8, 2024 | Health |
The chief executives of three major pharmaceutical companies are set to appear in front of the...
Read MorePosted by Times Reporter | Feb 7, 2024 | Entertainment |
We independently selected these deals and products because we love them, and we think you might...
Read MorePosted by Times Reporter | Feb 7, 2024 | Health |
Business at GE Healthcare Technologies capped off 2023 on a strong note despite ongoing concerns...
Read MorePosted by Times Reporter | Feb 6, 2024 | Business |
BP’s new chief executive, Murray Auchincloss, promised a flexible approach to the shift away from...
Read More